Lv11
40 积分 2024-06-20 加入
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
1小时前
待确认
Phase 3 trial results bring hope for patients with IgA nephropathy
1小时前
已完结
The susceptibility of CXCR3KO mice to EAE is associated with the increased numbers of Th17 infiltrating in CNS (60.4)
6天前
已关闭
Mechanisms of diabetic kidney disease and established and emerging treatments
14天前
已完结
Author Correction: Mechanisms of diabetic kidney disease and established and emerging treatments
14天前
已完结
Polycystin-1: a master regulator of intersecting cystic pathways
26天前
已完结
A new BRAF inhibitor breaks resistance barriers
1个月前
已完结
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
The SLC6A15–SLC6A20 Neutral Amino Acid Transporter Subfamily: Functions, Diseases, and Their Therapeutic Relevance
2个月前
已完结
Isoprostanes in dystrophinopathy: Evidence of increased oxidative stress
3个月前
已完结
皖公网安备34019202002308
